Artículos por temáticas

Aripiprazole Therapy and CYP2D6 Genotype

Dean L, Kane M.

2016 Sep 22 [updated 2021 Feb 10]. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kane MS, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–.

Atomoxetine Therapy and CYP2D6 Genotype

Dean L.

2015 Sep 10 [updated 2020 Jun 29]. In: Pratt VM, McLeod HL, Rubinstein WS, Scott SA, Dean LC, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–.

Functional immaturity of cortico-basal ganglia networks in Gilles de la Tourette syndrome.

Worbe Y, Malherbe C, Hartmann A, Pélégrini-Issac M, Messé A, Vidailhet M, Lehéricy S, Benali H.

Brain. 2012 Jun;135(Pt 6):1937-46. doi: 10.1093/brain/aws056.

A mouse model for triple-negative breast cancer tumor-initiating cells (TNBC-TICs) exhibits similar aggressive phenotype to the human disease.

Kaur P, Nagaraja GM, Zheng H, Gizachew D, Galukande M, Krishnan S, Asea A.

BMC Cancer. 2012 Mar 27;12:120. doi: 10.1186/1471-2407-12-120.

Widespread abnormality of the γ-aminobutyric acid-ergic system in Tourette syndrome.

Lerner A, Bagic A, Simmons JM, Mari Z, Bonne O, Xu B, Kazuba D, Herscovitch P, Carson RE, Murphy DL, Drevets WC, Hallett M.

Brain. 2012 Jun;135(Pt 6):1926-36. doi: 10.1093/brain/aws104.

Deep brain stimulation for Tourette syndrome: target selection.

Viswanathan A, Jimenez-Shahed J, Baizabal Carvallo JF, Jankovic J.

Stereotact Funct Neurosurg. 2012;90(4):213-24. doi: 10.1159/000337776. Review.

Increased sensory feedback in Tourette syndrome.

Biermann-Ruben K, Miller A, Franzkowiak S, Finis J, Pollok B, Wach C, Südmeyer M, Jonas M, Thomalla G, Müller-Vahl K, Münchau A, Schnitzler A.

Neuroimage. 2012 Oct 15;63(1):119-25. doi: 10.1016/j.neuroimage.2012.06.059.

Deep brain stimulation for treatment of refractory Tourette syndrome: long-term follow-up.

Porta M, Servello D, Zanaboni C, Anasetti F, Menghetti C, Sassi M, Robertson MM.

Acta Neurochir (Wien). 2012 Nov;154(11):2029-41. doi: 10.1007/s00701-012-1497-8.

Tourette syndrome in youth with and without obsessive compulsive disorder and attention deficit hyperactivity disorder.

Lebowitz ER, Motlagh MG, Katsovich L, King RA, Lombroso PJ, Grantz H, Lin H, Bentley MJ, Gilbert DL, Singer HS, Coffey BJ; Tourette Syndrome Study Group., Kurlan RM, Leckman JF.

Eur Child Adolesc Psychiatry. 2012 Aug;21(8):451-7.

Conversion of stationary to invasive tumor initiating cells (TICs): role of hypoxia in membrane type 1-matrix metalloproteinase (MT1-MMP) trafficking.

Li J, Zucker S, Pulkoski-Gross A, Kuscu C, Karaayvaz M, Ju J, Yao H, Song E, Cao J.

PLoS One. 2012;7(6):e38403. doi: 10.1371/journal.pone.0038403.

[Risk factors for Tourette syndrome].

Zhang HY, Liu CY, Wang YQ.

Zhongguo Dang Dai Er Ke Za Zhi. 2012 Jun;14(6):426-30. Chinese.

Public perception of Tourette syndrome on YouTube.

Fat MJ, Sell E, Barrowman N, Doja A.

J Child Neurol. 2012 Aug;27(8):1011-6. doi: 10.1177/0883073811432294.

Randomized trial of behavior therapy for adults with Tourette syndrome.

Wilhelm S, Peterson AL, Piacentini J, Woods DW, Deckersbach T, Sukhodolsky DG, Chang S, Liu H, Dziura J, Walkup JT, Scahill L.

Arch Gen Psychiatry. 2012 Aug;69(8):795-803. doi: 10.1001/archgenpsychiatry.2011.1528.

Atomoxetine-induced vocal tics in a patient with schizophrenia.

Raveendranathan D, Rao MG, Varambally S, Venkatasubramanian G, Gangadhar BN.

J Neuropsychiatry Clin Neurosci. 2012 Fall;24(4):E45-6. doi: 10.1176/appi.neuropsych.11110333. No abstract available.

Deep brain stimulation in tourette syndrome: a description of 3 patients with excellent outcome.

Savica R, Stead M, Mack KJ, Lee KH, Klassen BT.

Mayo Clin Proc. 2012 Jan;87(1):59-62. doi: 10.1016/j.mayocp.2011.08.005.